Skip to content
Resolve Therapeutics, LLC.
Resolve Therapeutics, LLC.Resolve Therapeutics, LLC.
  • About Us
    • Our Company
    • Management Team
    • SAB
    • Contact Us
  • Pipeline
    • Our Pipeline
  • Science
  • Sjögren’s Clinical Trial
  • Publications
  • News

Follow us on:

Linkedin page opens in new windowFacebook page opens in new window
  • About Us
    • Our Company
    • Management Team
    • SAB
    • Contact Us
  • Pipeline
    • Our Pipeline
  • Science
  • Sjögren’s Clinical Trial
  • Publications
  • News

Juan Pablo Tosar, Ph.D.

Recent Posts
  • Resolve Therapeutics Publishes Results of RSLV-132 Phase 2 Long COVID Study
  • Assessment of the Impact of RNase in Patients With Severe Fatigue Related to Post-Acute Sequelae of SARS-CoV-2 Infection (PASC): A Randomized Phase 2 Trial of RSLV-132
  • Resolve Therapeutics Announces Publication of Lupus Clinical Trial Results
  • Evaluation of RNase therapy in systemic lupus erythematosus: a randomised phase 2a clinical trial of RSLV-132
  • Resolve Therapeutics Completes Enrollment of Phase 2 Long Covid Clinical Trial
Resolve Therapeutics
Resolve Therapeutics, LLC
1951 NW 7th Ave.
Suite 300
Miami, FL 33136
© 2020 Resolve Therapeutics. All rights reserved.

Sitemap   Terms of Use   Privacy Policy  

Go to Top